Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 166 participants.
Also called NCT04982367
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 166 participants
- Sponsor
- Registry
-
NCT04982367
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04982367. Randomized; no masking; primary purpose treatment. Start 2021-12-08 (actual); primary completion 2024-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis
- Condition
- Peripheral Artery Disease
- Intervention (Device)
- Sirolimus-eluting balloon catheter
- Intervention (Device)
- Paclitaxel-eluting balloon catheter
- Lead sponsor
- Acotec Scientific Co., Ltd
Record details
- Record id
cardio:ct-nct04982367- Content hash
b2e8a152d7bd5a011e0f267d3eb6a38b8fc01c81d232917156197637299e7338